)
Biome Australia (BIO) investor relations material
Biome Australia Q2 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved record quarterly sales revenue of $6.5m in Q2 FY26, up 41% year-over-year, and rolling 12-month revenue of ~$22m.
EBITDA reached ~$1.0m for the quarter and ~$1.48m for 1H26, marking eight consecutive quarters of positive EBITDA (excluding share-based payments).
Strong cash generation enabled repayment of $722k into working capital facilities and a $421k increase in cash balance to $3.36m at quarter end.
Financial highlights
Gross margin maintained above 61% for Q2 FY26.
Cash receipts from customers were $6.2m, up 43% year-over-year.
Net operating cash inflow of ~$1.24m, including a $657k R&D rebate.
Inventory at quarter end was $3.9m (wholesale value $10m), up $500k from Q1.
Outlook and guidance
Management expects continued revenue growth to increasingly flow through to earnings and cash generation.
Focus remains on expanding international footprint and strengthening leadership in practitioner-only probiotics.
- TimeTickerHeadlineOpen
- 5 FebRBC
Q3 sales up 17% with strong Aerospace/Defense growth; Q4 revenue guided up 13.1–15.4%. - 5 FebABX
Record earnings, strong cash flow, and a North America gold IPO drive 2025 performance. - 5 FebMOD
Q3 sales and EBITDA surged on data center demand, but pension charge caused a net loss. - 5 FebBKH
2025 adjusted EPS up 5% to $4.10, with 6% growth guidance and a major merger pending. - 5 FebMUSA
Q4 2025 net income was $141.9M; 2026 guidance targets $439M net income and disciplined growth. - 5 FebNOV
Q4 revenue up 5% sequentially; strong cash flow and shareholder returns, but 2026 outlook cautious. - 5 FebGL
Earnings and premium growth drive higher 2026 guidance and continued share repurchases. - 5 FebARES
AUM up 29% to $622.5B, with record fundraising, earnings growth, and a 20% dividend hike. - 5 FebSKEL
NAV per share reached ISK 22.4, profit was ISK 4,297m, and a ISK 6,000m dividend was paid. - 5 FebCRNO
Advancing HDAC inhibitors for rare cardiopulmonary diseases, targeting major market and partnership milestones.
Next Biome Australia earnings date
Next Biome Australia earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)